# RyuWell

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ryuwell

- Headquarters: Naha-shi, Japan
- Website: www.ryuwell.com
- Latest round: Seed (Jan 31, 2026)
- Investors on record: 1

## About

Based in Japan, RyuWell Co., Ltd. specializes in health technology solutions that integrate medical expertise with advanced technology to enhance preventive healthcare and manage various health conditions.Founded in 2024 and headquartered in Naha-shi, Japan, RyuWell Co., Ltd. focuses on health technology solutions. The company has engaged in one deal as of January 31, 2026, reflecting its strategic approach to expanding its operations. Their founder, whose details are not provided, has a background that may include other ventures in the health technology space.RyuWell Co., Ltd. specializes in health technology solutions by integrating medical expertise with advanced technology. Their core offerings include preventive healthcare solutions, smart online diagnostics, and the analysis of real-world medical data. These products are designed to detect and manage conditions such as dementia and mental health disorders, ensuring that elderly residents can live with confidence and peace of mind. RyuWell collaborates closely with the Faculty of Medicine at Ryukyu University and current clinical researchers to address pressing healthcare challenges. The company's solutions primarily serve healthcare providers, including clinical and nursing environments, in the Okinawa region, focusing on enhancing healthcare delivery through technology innovations.The revenue model for RyuWell is structured around B2B partnerships, particularly with healthcare institutions and research organizations. The firm engages in subscription-based services for its health technology solutions, allowing healthcare providers access to ongoing updates and support. Pricing structures for specific products are tailored to the needs of institutional clients, potentially varying based on the type of services rendered or the size of the healthcare entity. RyuWell's flagship products, including its dementia diagnostic solutions, are positioned to enhance care delivery and clinical efficiency, thereby supporting revenue growth through increased adoption in the healthcare sector. Transactions occur directly between RyuWell and its clients, facilitating a streamlined process for implementing their technology solutions in various healthcare settings.In January 2026, RyuWell Co., Ltd. raised an undisclosed amount in Seed funding from new investor KSP. The company will utilize the funding towards research, development, and the social implementation of online and AI-based dementia diagnosis utilizing multimodal AI. RyuWell plans to design and launch new products aimed at enhancing their healthcare solutions. Additionally, the company is exploring expansion opportunities into new markets, although specific regions have not been disclosed.

## Funding rounds

- Seed, Jan 31, 2026 — KSP

## Investors

- KSP (https://capitalatlas.ai/funds/ksp) — Seed